News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Santos David A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/06/2023 |
4
| Santos David A (EVP, Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Sold 5,388 shares
@ $1.6602, valued at
$8.9k
|
|
| 01/30/2023 |
4
| Santos David A (EVP, Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 80,000 shares
@ $0
Granted 50,000 options to buy
@ $2.42, valued at
$121k
Granted 160,000 options to buy
@ $1.87, valued at
$299.2k
|
|
| 12/30/2022 |
4
| Santos David A (EVP, Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 50,000 options to buy
@ $2.42, valued at
$121k
|
|
| 01/26/2022 |
4
| Santos David A (EVP, Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 50,000 shares
@ $0
Granted 100,000 options to buy
@ $2.42, valued at
$242k
|
|
| 01/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2020 |
4
| Santos David A (EVP, Chief Commercial Officer) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 250,000 options to buy
@ $2.52, valued at
$630k
|
|
| 08/20/2020 |
3
| Santos David A (EVP, Chief Commercial Officer) has filed a Form 3 on RIGEL PHARMACEUTICALS INC |
|
|